Clinical profile and outcome of pancreatitis in children aged less than 15 years. by Senthil Aakash, K
  
CLINICAL PROFILE AND OUTCOME OF 
PANCREATITIS IN CHILDREN AGED LESS THAN 
15 YEARS 
 
Dissertation Submitted to 
 
THE TAMILNADU DR.M.G.R. MEDICAL UNIVERSITY 
CHENNAI, TAMILNADU 
 
In fulfillment of the regulations for the award of the degree 
 
M.D.(PEDIATRICS) 
 
 
 
DEPARTMENT OF PEDIATRICS 
PSG INSTITUTE OF MEDICAL SCIENCES & RESEARCH 
COIMBATORE, TAMILNADU 
 
APRIL 2016 
  
  
CLINICAL PROFILE AND OUTCOME OF 
PANCREATITIS IN CHILDREN AGED LESS THAN 
15 YEARS 
 
 
In fulfillment of the regulations for the award of the degree 
 
M.D. (PEDIATRICS) 
 
 
 
GUIDE 
DR. JOHN MATTHAI 
 
DEPARTMENT OF PEDIATRICS 
PSG INSTITUTE OF MEDICAL SCIENCES & RESEARCH 
THE TAMILNADU DR.M.G.R.MEDICAL UNIVERSITY 
CHENNAI, TAMILNADU 
 
APRIL 2016 
 
  
  
DECLARATION 
 
I hereby declare that this dissertation entitled "CLINICAL PROFILE 
AND OUTCOME OF PANCREATITIS IN CHILDREN AGED LESS 
THAN 15 YEARS" was prepared by me under the guidance and supervision of Dr. 
JOHN MATTHAI, Professor and Head of the Department of Pediatrics, 
PSGIMS&R, Coimbatore. 
 
This dissertation is submitted to The Tamilnadu Dr. M.G.R Medical 
University, Chennai in fulfillment of the university regulations for the award of MD 
degree in Pediatrics. This dissertation has not been submitted elsewhere for the award 
of any other Degree or Diploma. 
 
 
       Dr.SENTHIL AAKASH. K 
 
 
 
 
 
 
  
  
CERTIFICATE 
 
This is to certify that the thesis entitled "CLINICAL PROFILE AND 
OUTCOME OF PANCREATITIS IN CHILDREN AGED LESS 
THAN 15 YEARS" is the bonafide work of  Dr.SENTHIL AAKASH. K, done 
under my guidance and supervision in the Department of Pediatrics, PSG IMS&R, 
Coimbatore in fulfillment of the regulations laid down by The Tamilnadu Dr. M.G.R. 
Medical University for the award of MD degree in Pediatrics. 
 
 
 
 Dr. JOHN MATTHAI 
 Professor and  
 Head of the Department 
 Department of Pediatrics 
 PSG IMS & R 
 
 
 
 
 
  
  
CERTIFICATE 
 
This is to certify that the thesis entitled "CLINICAL PROFILE 
AND OUTCOME OF PANCREATITIS IN CHILDREN AGED 
LESS THAN 15 YEARS" is the bonafide work of Dr.SENTHIL AAKASH.K 
done under the guidance of Dr. JOHN MATTHAI, Professor and Head of the 
Department of Pediatrics, PSG IMS&R, Coimbatorein fulfillment of the regulations 
laid down by The Tamilnadu Dr. M.G.R. Medical University for the award of MD 
degree in Pediatrics. 
 
 
 
Dr. JOHN MATTHAI    Dr. RAMALINGAM 
Head of the Department    Dean 
Department of Pediatrics    PSGIMS&R  
PSGIMS&R 
 
 
 
  
  
 
  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
  
  
ACKNOWLEDGEMENTS 
I am extremely grateful and indebted to my guide                                         
Dr.JOHN MATTHAI, Professor and HOD, Department of Pediatrics, PSGIMS&R, 
for his invaluable guidance, concern, supervision and constant encouragement to 
complete this dissertation. 
I extend my sincere gratitude to Dr. SARAH PAUL, Professor, Department of 
Pediatrics, PSGIMS&R, who gave her unflinching support and invaluable advice in 
preparing this dissertation. 
           I wish to express my gratitude to Dr.A.M.VIJAYALAKSHMI, &                       
Dr. K.JOTHILAKSHMI, Professors, Department of Pediatrics, PSGIMS&R, for 
their constant support and motivation to complete this work 
           I sincerely thank Dr.N.T.Rajesh Associate Professor department of Pediatrics, 
PSGIMS&R for his valuable suggestions throughout the study period. 
I also thank Dr. Venkateshwaran, Dr. Sivanandam, Dr. Ramesh,                   
Dr. Nitin Srinivasan, Dr. Jayavardhana, Dr. Bharathi, and Dr. Nirmala for their 
support and assistance in helping me to complete this work. 
I am very thankful to my colleagues Dr. Vignesh , Dr. Kumaraguru  and           
Dr. Venkatesh Rao  for their constant support. I also thank my juniors and all other 
friends for their support. 
I also express my gratitude to the Principal and Dean, faculties of ethical 
committee of PSG IMS & R for granting me the permission to conduct the study. 
  
I’m very grateful to my Father Mr. P.Kandasamy and Mother                        
Mrs. K.Shanthy for their love and affection. 
I am extremely grateful and obliged to all the patients without whom this study 
would not have been complete. 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
TABLE OF CONTENTS 
S.NO CONTENTS PAGE NO 
1. INTRODUCTION  1 
2. OBJECTIVES  3 
3. REVIEW OF LITERATURE 4 
4. MATERIALS AND METHODS 43 
5. RESULTS 47 
6. DISCUSSION 68 
7. CONCLUSION 76 
8. BIBLIOGRAPHY 78 
9. ANNEXURES  
 LIST OF ABBREVIATIONS  
PROFORMA 
CONSENT AND ASSENT FORM 
MASTER CHART 
85 
86 
88 
96 
 
 
 
 
 
  
  
LIST OF FIGURES 
S.NO. CONTENT PAGE 
1 STRUCTURE OF PANCREAS 5 
2 RELATIONS OF PANCREAS 6 
3 DUCTS OF PANCREAS 8 
4 ARTERIAL SUPPLY OF PANCREAS 9 
5 VENOUS DRAINAGE OF THE PANCREAS 12 
6 LYMPHATIC DRAINAGE OF PANCREAS 13 
7 NERVE SUPPLY OF PANCREAS 15 
8 ULTRASTRUCTURE OF THE PANCREAS 16 
9 HISTOLOGICAL STRUCTURE OF PANCREAS 18 
10 GALL STONES IN ACUTE PANCREATITIS 23 
11 TYPES OF PANCREATIC DIVISUM 24 
12 SUPPRESSION MECHANISM IN ACUTE 
PANCREATITIS 
28 
13 ULTRASOUND ABDOMEN SHOWING BULKY 
PANCREAS AND PERIPANCREATIC FLUID 
COLLECTION 
33 
14 CT ABDOMEN SHOWING PSEUDOCYST AND 
CALCIFICATION OF PANCREAS 
35 
15 MAGNETIC RESONANCE 
CHOLANGIOPANCREATOGRAPHY OF 
PANCREAS 
36 
16 ENDOSCOPIC RETROGRADE 
CHOLANGIOPANCREATOGRAPHY OF 
PANCREAS 
37 
17 PERCUTANEOUS PSEUDOCYST DRAINAGE 41 
18 SPHINCTEROTOMY WITH STENTING 42 
 
  
S.NO. CONTENT PAGE 
19 AGE OF THE CHILDREN AT PRESENTATION 48 
20 GENDER DISTRIBUTION OF CHILDREN WITH 
ACUTE PANCREATITIS 
49 
21 ETIOLOGICAL FACTORS IN ACUTE 
PANCREATITIS 
51 
22 SYMPTOMS IN ACUTE PANCREATITIS 53 
23 INVESTIGATIONS IN ACUTE PANCREATITIS 55 
24 PSEUDOCYST IN ACUTE PANCREATITIS 56 
25 RECURRENCE RATE IN ACUTE PANCREATITIS 57 
26 AGE DISTRIBUTION OF CHILDREN WITH 
CHRONIC PANCREATITIS 
58 
27 GENDER DISTRIBUTION IN CHRONIC 
PANCREATITIS 
59 
28 ETIOLOGICAL FACTORS IN CHRONIC 
PANCREATITIS 
60 
29 SYMPTOMS IN CHRONIC PANCREATITIS 61 
30 INVESTIGATIONS IN CHRONIC PANCREATITIS 62 
31 MANAGEMENT IN CHRONIC PANCREATITIS 63 
32 CALCIFICATION IN CHRONIC PANCREATITIS 64 
33 PSEUDOCYST IN CHRONIC PANCREATITIS 65 
 
  
  
LIST OF TABLES 
NO. TABLE PAGE 
1 CAUSES OF PANCREATITIS 21 
2 DIFFERENCES BETWEEN MRCP AND ERCP 38 
3 AGE OF THE CHILDREN AT PRESENTATION 48 
4 GENDER DISTRIBUTION OF CHILDREN 
WITH ACUTE PANCREATITIS 
49 
5 ETIOLOGICAL FACTORS IN ACUTE  
PANCREATITIS 
50 
6 SYMPTOMS IN ACUTE PANCREATITIS 52 
7 INVESTIGATIONS IN ACUTE PANCREATITIS 54 
8 PSEUDOCYST IN ACUTE PANCREATITIS 56 
9 RECURRENCE RATE IN ACUTE 
PANCREATITIS 
57 
10 AGE DISTRIBUTION OF CHILDREN WITH 
CHRONIC PANCREATITIS 
58 
11 GENDER DISTRIBUTION IN CHRONIC 
PANCREATITIS 
59 
12 ETIOLOGICAL FACTORS IN CHRONIC 
PANCREATITIS 
60 
13 SYMPTOMS IN CHRONIC PANCREATITIS 61 
14 INVESTIGATIONS IN CHRONIC 
PANCREATITIS 
62 
15 MANAGEMENT IN CHRONIC PANCREATITIS 63 
16 CALCIFICATION IN CHRONIC 
PANCREATITIS 
64 
17 PSEUDOCYST IN CHRONIC PANCREATITIS 65 
 
 
  
INTRODUCTION 
 
  Pancreatitis is characterized by inflammation of the pancreas, clinical 
signs of epigastric abdominal pain and elevated levels of pancreatic enzymes in 
the serum. Acute pancreatitis, which is reversible is characterized by edema of 
the interstitium, inflammatory cell infiltration with varying degrees of necrosis, 
apoptosis, and hemorrhage [1]. In chronic pancreatitis, non reversible change 
takes place in the structure and functioning of the pancreas. Fibrosis and 
infiltrated cells can cause exocrine problems or endocrine problems or both [2]. 
Acute pancreatitis is becoming a relatively more common disease even in 
children. In adolescents, the disease tends to be more severe. 
 
Acute pancreatitis must be considered in any child with severe upper 
abdominal pain associated with vomiting, and appropriate therapy must be 
instituted at the earliest. Many studies have shown an increase in the incidence 
of pancreatitis in children over the past 10-15 years. [3 ]. In around 20-40% of 
the children, no cause is identified and is called idiopathic. Among the 
remaining children, gall stones, trauma and drugs are the leading causes of 
pancreatitis[4]. Though pancreatitis in children presents with a wide variety of 
symptoms, abdominal pain remains the most common symptom at the time of 
presentation in most studies.  
  
There is sparse data regarding the profile of acute and chronic pancreatitis 
in children particularly from the developing countries. This study was 
undertaken to profile the clinical features, etiology and outcome of acute and 
chronic pancreatitis in children.                                      
  
  
OBJECTIVES 
 
• Primary Objective: 
                 To study the etiology, presentation and management of 
pancreatitis in children less than 15 years.  
 
• Secondary Objective:   
                   To determine the complication and recurrence rate of 
pancreatitis in children. 
 
 
 
 
  
  
REVIEW OF LITERATURE 
 
History :  
                         Pancreas was referred as  “finger of the liver” in Talmud,  
which was mentioned many years back. Vesalius thought that pancreas was a 
cushion for the stomach.  Galen realised that pancreas will give protection and 
support to the vessels in the body. Wirsung  explained  about the ducts within 
the pancreas of human beings in 1642 .  de Graaf  explained about the secretion 
of the gland pancreas from the fistula of pancreas of dogs. The digestive activity 
of pancreatic gland was demonstrated much later. Later, Eberle and Purkinje 
and explained about pancreatic activity of  emulsifying fat, proteolysis activity, 
and digesting activity by pancreatic enzyme secretions. Subsequently, Bernard  
described  the digesting activity of pancreatic secretions on lipids, carbohydrates 
and proteins. In the year of 1876, Kuhne coined the term as enzyme and 
extracted trypsin .  In 1889, Chepovalnikoff,  discovered enterokinase in the  
mucosa of the duodenum. It is required for activating  the proteolytic enzymes.  
In 1895, Dolnsky stimulated the secretions in the pancreas by pouring acid into 
the duodenal mucosa. These things made the discovery of the hormone secretin 
by Baylis. It is the first hormone to be identified. In 1869, Langerhans described 
the histologic structure of the pancreas. Shortly After that, Hidenhain 
demonstrated changes in the postprandial state that happened in the dog.  
Friedreich was the first person who described pancreas systematically in 1875. 
  
ANATOMY 
Figure 1: Structure of Pancreas 
 
 
 
 
 
 
 
 
 
 
The pancreatic gland is soft, which is slightly flattened and also elongated 
[4-6]. The head of pancreas lies underneath the peritoneal layer of the posterior 
wall of the abdomen and it has a structure resembling that of a lobule. The 
pancreatic gland does not have a true capsule. It is covered with a fine 
connective tissue. The pancreatic head lies on the right end and is placed in the 
curve of the duodenum. The body of pancreas, neck, and the pancreatic tail lie 
in an oblique fashion in the posterior part of the abdomen. The tail of pancreatic 
organ reaches till the gastric side of the spleen. The 2
nd
 and 3
rd
 curvatures of the 
duodenum lie encircling the pancreatic head. The anterior surface of the 
pancreatic head lies adjacent to the pyloric region of stomach, the 1
st
 part of 
  
duodenum, and transverse part of the colon. The posterior surface touches the 
hilum and medial surface of  right kidney, the right gonadal vein,  the right renal 
vessels and the inferior vena cava. The uncinate process of pancreas is usally a 
prolonged part of the pancreas with different shapes and size. It usually extends 
from the lower portion of head, and extends in upward direction and to left side. 
The uncinate process of pancreas lies just anterior to inferior vena cava and the 
aorta. The uncinate process is covered above by the superior mesentric vessel. 
The uncinate process may also not seen. 
Figure 2: Relations of Pancreas 
 
 
 
 
 
 
 
 
  
The pancreatic neck appears to be constricted and it extends from the 
head towards the left, joining with the body of the pancreas. The joining of the 
portal vein with superior mesenteric vein and splenic vein lies posterior side of  
the neck of  pancreas . Anteriorly, the neck of pancreas is enveloped by pyloric 
part of stomach and peritoneal layer of  lesser sac. The body of the pancreas lies 
infront of the major blood vessel aorta. It lies behind the peritoneam and is held 
towards the aorta by the lesser sac peritoneum. The anterior surface of the body 
of pancreas is covered by peritoneal layer of the omental bursa. The antrum 
portion and body part of the stomach had contact with the body of pancreas on 
the anterior side. Posteriorly,  body of the pancreas is related to the aorta, the 
origin of the SMA, the left kidney, the left adrenal gland, the left crus of the 
diaphragm. The middle of the body of pancreas lies over the lumbar spine. This 
part is mostly injured in case of any trauma to abdomen. Between the body and 
the tail, there is no junction point. The tail of the pancreas is  mobile, and its tip 
reaches the splenic hilum.  The tail of  pancreas lies between the two layers of 
the splenorenal ligament. 
 
The duct of Wirsung originates near the tail end of the pancreas. It is 
formed by joining the ductules which drain the lobules. It usually drains into 
major duodnal papilla. The accesory duct ( duct of santorni ) usually joins with 
the main duct and it drains into minor papilla [7].  
 
  
Figure 3: Ducts of Pancreas 
 
  
Figure 4
 
 
 
 
 
 
 
 
 
 
 
 
 
The pancreatic gland is well circulated and it is supplied by 
the celiac artery and SMA [8,9]. 
pancreatcoduodenal arterial arcades. They are form
postero superior pancreatcoduodenal a
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pancreaticoduodenal artery lies on the surface of the pancreatic gland. It gives 
its branches to the anterior part of the duodenum, proximal part of the jejunum, 
and pancreas. The artery then enter into the  pancreas and, on the posterior side, 
join with the anteroinferior pancreatcoduodenal artery from the SMA. The 
anteroinferior pancreatcoduodenal artery arise from the SMA at the inferior end 
of the pancreatic neck.  
 
The posterinferior pancreatcoduodenal artery arises from the 
gastrduodenal artery. Its course is there on the posterior side of pancreas, and  
may join with branches of the gastroduodnal artery or with a branch from dorsal 
pancretic artery. It passes posteriorly to the pancreatic portion of the bile duct. 
In the neck of pancreas, the dorsl pancretic artery arises from the splenic artery. 
From here, a right branch usually gives blood supply to the head and joins the 
posterior vessels. It also supplies and then gives  branches that carry through the 
body of the pancreas and tail, often having connections with some of the 
branches of the spleenic artery and a more distal end connection with the 
spleenic or the left gastrepiploc artery.  
 
All other major arteries usually lie posterior to the ducts. The course of 
the spleenic artery lies posterior to the distal portion of pancreas and it encircles 
above and below the upper margin of the pancreatic gland. The dorsal pancretic 
artery,  joins with one of the posterior arcades after branching the inferor 
pancretic artery. The caudal pancretic artery usually get arised from the L. 
  
gastroepiploc artery or from a splenic branch . It then joins with branches of the 
spleenic and some great pancretic arteries and with other pancreatic arteries. 
(Figure 4 ) 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 5: Venous drainage of the pancreas 
 
        Generally, the venous system of  pancreas is like that of the arterial supply. 
It drains into the portal system, and the system which is mainly draining the 
pancreas  is formed by the combination of the superor mesenteric vein  and the 
splenic veins behind the neck part of the pancreas. The portal vein gets behind 
the pancreas gland and is situated to the front of the IVC, with the bile duct to 
right and on the left side by the hepatic artery. The spleenic vein starts at the 
hilum part of the spleen and usually forms a curve behind the tail portion of the 
pancreas and underneath the spleenic artery, to the right side along the posterior 
region of the pancreatic gland. The pancreatic veins originates from the the neck 
of the pancreas,its body, and tail portion of the pancreas and join the splenic 
vein. The pancreticoduodenal veins run very close proximity to their pancreatic 
arteries and drain into the sple
the splenic vein with pancreatic gland
the pancreas  can lead to occlusion of the
backward flow toward the sple
gastroepiploc veins, can cause
 
LYMPHATIC DRAINAGE
 
Figure 6 : Lymphatic drainage of pancreas
 
The lymphatics in the pancreas
toward regional nodes which lie near the large
superior group of lymphatics pass
close proximity with the sple
 
enic or portal veins. Due to the close proximity
,any inflammation or neoplasm  involving 
 splenic vein. Due to this, there is 
enic hilum and then, through the gastric and left 
 gastric varices. (Figure 5 ) 
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the pancreas drain into nodes in the spleenic hilum. Those lymphatics on the 
right side  and near to the body and the neck empty into lymph nodes near the 
upper end of the head. They also receive lymphatic drainage from the anterior 
surface and posterior pancreatic surfaces. The inferor lymphatic vessel run with 
the inferor pancretic artery. Those that drain the lower left side of the body and 
tail drain toward nodes in the splenic hilum. The remaining portions of the neck 
and body drain toward the right. Lymphatic vessels drainage of the head of the 
pancreas is broadly divided into an anterior lymphatic system and a posterior 
lymphatic system. These vessels usually lie in the grooves in between the head 
and the duodnum, near the pancreatcoduodenal blood vessels. Each group of 
drainage system (i.e anterior group and posterior) also has subgroups-  superior 
and inferior type of drainage systems. In addition to this, a separate set of 
lymphatics vessels also drains the upper part of the head, which lies on the 
superior border. The lymphatics of the head of pancreas and duodenal part  
flows into the celiac group and superior mesenterc groups of pancretic nodes 
and then drainsinto the cisterna chyli.  
 
The lymphatic supply of the tail of the pancreas drain into spleenic hilar 
nodes and the lymphatics of the body of the pancreas pass to the 
pancreatcosplenic nodes which lies alongwith the superior  border,and then it 
drains into the coeliac nodes. Lymphatic drainage of the upper part of  head of 
the pancreatic gland pass through subpyloric group of nodes. In the inferior 
  
portion, lymphatics drain into the retropancretic and antepancretic nodes, which 
then joins and then drains into superior mesenteric group of nodes. ( Figure 6 ) 
 
INNERVATION 
  
     
           
 
 
 
 
 
 
 
 
Figure 7 : Nerve supply of pancreas 
                  
The visceral main efferent nerve supply of the pancreas is by the vagus 
and splanchnc nerves by the hepatic nerve plexus and coeliac plexuses. The 
efferent nerves of the vagus does not synapse and pass through and end in 
parasympathetic ganglia which is there in the intrlobular septa of the pancreatic 
gland. The postganglionc nerve fibers gives nerve supply to pancreatic acini, 
islet cells, and the ducts. The neurons of the sympathrtic efferent nerves begins 
in the lateral part of the grey matter of the thoracic part and lumbar part of the 
  
spinal cord. The nerve bodies of the postganglionc sympathetc neurons are 
situated in the great plexus within  the abdomen. Their postganglionc fibers 
provides nerve supply to only blood vessels. The autonomc fibers are situated in 
close proximity to the blood vessels of pancreas. Nothing much is known 
regarding the distribution of the visceral group efferent fibers in humans. They 
mostly run through the splanchnc nerves to the sympathatic trunks and rami 
communictes and through spinal nerves and through ganglia. The vagus also 
carry some visceral efferent fibers. ( Figure 7 ) 
 
HISTOLOGY AND ULTRASTRUCTURE: 
 
                                   
 
 
 
 
 
 
 
 
 
 
Figure 8 : Ultrastructure of the pancreas 
  
The pancreatic gland is a compound structure, which is nodular  that is 
similar in structure to salivary glands but it is less compact than that. Though 
connective tissue surrounds it, there is no fibrous capsule. The lobules within 
the gland are visible on examination and connective tissue is present which 
connects the lobules and it embeds the vessels, excretory ducts and the nerves. 
As it is a mixed gland, it contains both exocrine cells which is in majority and 
endocrine cells in less number.  The endocrine part of the gland which is less in 
number consists of the  Langerhns cells. They are rounded cells which are in 
clusters and are present throughout the pancreatic gland.  
 
The exocrine part of the pancreas has many  acini which is composed of 
tubular mass and rounded masses of cells, and they are the subunits of the 
lobule[12,13].( Figure 8 ). Silicon type of casts in the lumen of the duct formed 
by retrograde injection generally indicate that the  acini are more in number and 
the  cells are mainly curved, branching type of tubules that get anastomosed and 
ends blindly . The secretory duct originates from the acini lumen and it contains 
centroacnar cells, and these cells are unique to pancreas. The centroacinar cells 
stain pale in histological sections and relatively smaller than the acinr cells. 
Columnar epithelial cells covers the intralobular ducts and the acini lumen gets 
into the ducts . These intralobular ducts are not striated and they anastomose 
with each other to form the interlobulr ducts, and columnar type of epithelium 
lines this. Goblt  and occasional argentafin cells also are seen. The interlobulr 
  
ducts anastomose with each other to form the main pancreatc duct. Connective 
tissue and elastic fibers are present in large ducts.  There is a central lumen with 
a broad base and the acinar cells are lined by columnar epithelial cells. Many 
number of  eosinophilc zymogen granuls present in the apical part of the cell in 
the resting state.  spherical nuclei and basophilic cytoplasm are present in the 
cells basal portion. Inbetween the nucleus and granules lies the golgi complex 
and it is a nonstaining region . After feeding and digestion, the acinar cells 
usually have  cyclical changes in the morphology. After having a large meal, the 
acinar cells zymogen content is lost. There will be a reduction in both the 
number and size of granules. ( Figure 9 )  
 
Figure 9 : Histological structure of pancreas 
 
  
PANCREATIC SECRETIONS:  
                        
 
 
     
 
 
 
 
 
 
 
 
 
 
 Pancreatic secretions play a major role for digestion and also function as 
hormones in the endocrine system. The enzymes secreted by the pancreas which 
aids in digestion are lipase, amylase and proteases. The hormones secreted by 
the gland are glucagon, insulin, somatostatin and pancreatic polypeptide 
  
  
ETIOLOGICAL FACTORS OF ACUTE PANCREATITIS  
 In adults, most of the pancreatitis episodes are due to cholelithiasis or 
induced by alcohol, but in childhood pancreatitis, the etiologies are much 
different. We could not clearly classify the etiology in children due to 
differences in their prevalence in various studies. This difference in the 
causative factors is mainly due to retrospective nature in which most of the 
studies were conducted. As investigations are not complete, this also can further 
complicate the issues. As nowadays many etiologies are newly recognized, the 
categories can be splitted into more number. The currently available data 
regarding pancreatitis suggests that drugs, biliary disease, traumatic causes, 
systemic disease,and idiopathic followed by  metabolic causes, pancreatitis due 
to infections and hereditary with family history of pancreatitis are the common 
causes. [3,4,16-19,20-23].( TABLE 1) 
 
 
 
 
 
 
 
                                 
  
  
TABLE 1 :  CAUSES OF PANCREATITIS 
 
 
               
 
 
  
Biliary tract disease 
Gallstones or presence of sludge within the gallbladder was seen in 
around 20-30% children with pancreatitis.[3,4,16,18,21-25,]. The defects in the 
structure of pancreas like pancreatic divisum and Oddi sphincter dysfunction are 
also included under biliary causes. Tumours or stones cause biliary obstruction 
leading to pancreatitis in the adults but  in children biliary sludge constitutes 
major part [3,4,18,22].  In children, most of them have sludge in the gall bladder 
and not fully formed stones which leads to this difference in etiology. The child 
with pancreatitis when caused due to biliary pathology, they have elevated 
SGPT and SGOT levels with raised serum bilirubin[22]. The stone shall be 
removed by ERCP in case the obstruction persists for more than 3 days or if 
cholangtis or  pancreatits gets worsened.  At present, there is no clear evidence 
regarding the treatment of sludge but some clinicians used ursodiol for 
managing these children. But they were not sure that pancreatitis got improved 
and there is free flow of bile as the obstruction was cleared both occurred in a 
spontaneous way or due to drugs. Children having biliary stones, surgical 
removal of gall bladder should be done within 4 weeks as per the guidelines. If 
the pancreatitis was recurrent only, surgical removal was indicated otherwise it 
is not needed. ( Figure 7 ) 
                               
                             
  
Figure 10 :  Gall stones in acute pancreatitis
 
Pancreatic divisum 
It is a congenital anomaly in which instead of a single duct there are 2 
ducts. There are 3 types- classical, absent ventral duct and functional. 
 
                            
                                    
  
 
 
 
 
  
 
Figure 11 : Types of pancreatic divisum 
 
Drugs: 
In only less than one fourth of cases of pancreatitis, drugs were postulated 
as causing pancreatitis[3,4,15,16,19,21,23,24]. The drugs mainly causing the 
disease were valproic acid, asparginase and prednisolone. The study persons are 
not aware of what is the relation between the ingestion of the drug and 
development of pancreatitis and whether any mechanism was available behind 
this. Many children who take drugs also have some systemic disorders so we are 
not aware pancreatitis is caused either by those drugs or by the systemic 
disorder.  
 
  
Idiopathic : 
Even nowadays despite having many efficient investigations and many 
detection techniques, idiopathic pancreatitis ranged from 15 to 40% [3,4,17-
19,20,22,23,24-26]. So there is no decrease in the incidence of the idiopathic 
disease despite having these finding modalities. 
 
Systemic disease : 
Many systemic associated diseases like cystic fibrosis, HUS, SLE, sepsis 
and shock can also be a cause of the disease or can be associated with 
pancreatitis[3,16-18,19,25]. But it was not clear whether the raise in incidence 
was due to the disease per se or due to raising number of systemic disorders.  
 
Traumatic cause : 
Trauma as a cause of pancreatitis was seen in about one third of children. 
[3,4,15-18,20,22-27]. Children will easily get hurt by playing sports or road 
traffic accidents or due to any abuse to the child. 
 
Infectious causes: 
Pancreatitis caused by infections were seen in less than 10% of the 
children [3,4,15-18,20,22-27]. In this too, like in drugs and systemic diseases, 
whether pancreatitis and infections are associated with each other was not well 
understood. They usually present with symptoms of  respiratory tract infections 
  
like fever, coryza etc . Some viral causes which are closely related are varicella 
[29,38] , mycolasma[30], hepatitis A[32-34] , mumps[22,26,40], rota virus[35-
37] and coxsakie virus[39]. 
  
Metabolic causes : 
The common metabolic derangements which leads to pancreatitis are 
increase in calcium and triglyceride levels[15,23]. It can be seen in less than 
10% of children[3,4,16,17,19,21,23]. These children often presents with 
recurrent pancreatitis because they often have metabolic derangements which 
will cause pancreatitis. But the exact reason why metabolic disturbances cause 
the disease is not well understood. The main modalities of management for 
these type of children is to correct the underlying disease. For 
hypertriglycerdemia, lipid reducing agents and statins should be administered. 
Many children presenting with increased calcium levels may be due to 
hyprparathyrodism so surgiacal removal of the gland is mandatory for treating 
these kind of children.  
 
Hereditary cause : 
Family history of pancreatitis also plays a significant role in diagnosing 
the cause of pancreatitis. It was found hereditarily in around 5% children due to 
various mutations like SPINK and PRSS[3,17,18]. The history of the family 
  
members with detailed history about the past 2 generations and the genetic 
study are essential ti diagnose hereditary pancreatitis. The occurrence of 
pancreatitis in a hereditary way was mainly because of loss of protective 
mechanisms but the exact cause is not well understood. 
 
PATHOPHYSIOLOGY : 
The pathophysiology of acute pancreatitis was not clearly understood. 
According to previous studies, in the acinar cells of the pancreas there is 
premature pancreatic enzymes activation which leads to injury of the acinar 
cells[30]. This activation of the enzymes is mainly because of generation of 
calcium signals. Activated trypsin mainly leads to the cell injury and it produces 
cytokines of wihich TNF alpha is the major cytokine which causes 
pancreatitis[42]. It leads to inflammation in and around the pancreas. There is 
pancreatic ischemia due to the inflammation, or in some cases may cause 
pancreatitis. There are many protecting mechanism in the humans against 
pancreatitis such as SPINK which is a trypsin inhibitor and there also occurs 
autodegradation of trypsin. There are many ways in which pancreas can 
regenerate after it was destroyes by the enzymes. Melatonin can favour 
regeneration by increasing the synthesis of  DNA[44].  So in the future with 
new modalities of investigations and managing techniques, the exact 
pathogenesis of pancreatitis can be studied and treatment option which is 
specific for the disease can be explained. 
  
 
Figure 12 : Suppression mechanism in acute pancreatitis 
 
MAGNITUDE OF THE DISEASE :  
The incidence of acute pancreatitis in children is in a rapidly raising trend 
and there is much increase in the number of admissions with acute or chronic 
pancreatitis[3,15]. Acute pancreatitis in children is a costly and increasingly 
recognized disease. In adults also the disease is on the raising trend and the 
pediatric incidence is also started increasing. This can be attributed to many 
reasons , due to increase in the incidence of systemic diseases or better health 
care facility that many children are referred to tertiary care center. The reasons 
for this increase are not entirely understood and shall be due to multifactorial 
causes. As many children are referred to tertiary care centres where many 
  
controlled trials are undertaken, it obviously leads to increase in the incidence of 
pancreatitis but this does not reflect the real situation. There is a  correlation 
regarding investigating the child with more in number of s. amylase and s. 
lipase tests suggests that there is more proclivity for diagnosing pancreatitis. So 
the recent increase in the incidence of pancreatitis was due to combination of 
many factors like recent changes in the diagnosis and managing these children. 
Pancreatitis in children has become a major burden in both social and economic 
ways as they have to spend for attending the outpatient department, for getting 
admitted, for undergoing investigations and many imaging studies which have 
become costlier nowadays. As the average duration of hospital stay will be more 
than 5 days, large amount of money was spent on hospital stay itself. In case of 
surgical intervention, again huge sum of money should be spent which will be a 
huge burden on the family in the present economic status. They should also 
spend considerable amount of money for revisits and if they develop any 
complications. The family members of the child also have loss of pay for 
bringing the child to hospital and loss of working time[4,45]. So pancreatitis has 
a significant economic and health burden than what was thought earlier. 
 
  
  
PRESENTATION 
In the studies done in children, the most common clinical presentation is 
of abdominal pain and vomiting[19,27,40,46]. Abdominal pain is present in 
more than 90% of the children presenting with pancreatitis and vomiting around 
50 % of the children. The site of the abdominal pain can vary from a child to 
child. But many children have epigastric pain and some have diffuse abdominal 
pain[47,48]. Some children have pain localized to the right side of the abdomen. 
The next common presenting feature is vomiting which may be bilious or non 
bilious and around 50% children presents with vomiting[3,16,19,20,24,25]. 
Other common presenting features are fever, distention of the abdomen, any 
bleeding manifestations like hemetamesis or melena. The epigastric pain can 
also radiate to the back. The child with acute pancreatitis can also present to the 
emergency in shock and it can be the only manifestation at the time of 
admission. In very young children, irritability was a major complaint . The next 
common presenting feature is vomiting which may be bilious or non bilious and 
around 50% children presents with vomiting. Other common presenting features 
are fever, distention of the abdomen, any bleeding manifestations like 
hemetamesis or melena[19,27,46]. In some cases there is bluish discolouration 
in the flanks which is termed as Gray Turner sign. The  presence of bluish 
discolouration or ecchymoses near  the umbilicus was termed Cullens sign. 
toddleesn were compared with children between 3 and 20 years of age.  
  
DIAGNOSIS : 
Since the pancreas cannot be sampled histologically, it is usually 
diagnosed by clinical presentation and the investigations like the biochemical 
parameters and multiple imaging modalities. Many diagnostic criteria have been 
adapted for diagnosing acute pancreatitis. It includes the presenting symptom 
which in most cases is abdominal pain, elevation of  biochemical parameters 
liks serum lipase more than thrice of the upper limit of the normal values and 
ultrasound or computed tomography findings like bulky pancreas, 
peripancreatic fluid collection, increased echogenecity of the pancreas[1].  
 
Children presents with abdominal pain which is usually noticed in the 
epigastric region and they can experience reffered pain to the back. In some 
children, the pain can be diffuse and even lead to rebound tenderness. Other 
most common presenting features are abdominal distention, fever, bleeding 
manifestations like hemetamesis or melena. Many diagnostic criteria have been 
adapted for diagnosing acute pancreatitis.  Most of this criteria include the 
presenting symptom which in most cases is abdominal pain, elevation of  
biochemical parameters liks serum lipase more than thrice of the upper limit of 
the normal values and ultrasound or computed tomography findings like bulky 
pancreas, peripancreatic fluid collection, increased echogenecity of the pancreas  
 
  
BIOCHEMICAL PRESENTATION 
The most common tests done for pancreatitis are serum amylase and 
serum lipase. The levels of both are elevated in pancreatitis but serum lipase is 
more specific for pancreatitis than amylase while serum amylase is more 
sensitive [3,16,27,40]. Serum lipase is elevated in more than 90% of the 
children while amylase levels are elevated in around 60-80% of children 
[3,4,20,24,25]. Other investigations done for pancreatitis are total white blood 
cell count which will be elevated in around 30-40% cases. There will be 
neutrophilic leukocytosis or relative neutrophilia. C-reactive protein test was 
also done which will be elevated in the same number of cases. The levels of 
both are elevated in pancreatitis but serum lipase is more specific for 
pancreatitis than amylase while serum amylase is more sensitive. Serum lipase 
is elevated in more than 90% of the children while amylase levela are elevated 
in around 60-80% of children[20,24,25].  
 
Serum lipase will be elevated more than 3 fold and it is significant and 
more than 5 fold increase above the baseline value will also be seen. Blood 
sugar levels may also raise and it should also be monitored. serum amylase and 
lipase can also get elevated due to non pancreatic reasons so it should also be 
taken into count before coming to a conclusion.  investigations done for 
pancreatitis are total white blood cell count which will be elevated in around 30-
40% cases. There will be neutrophilic leukocytosis or relative neutrophilia. C-
  
reactive protein test was also done which will be elevated in the same number of 
cases. Some other biochemical investigations can also be done which are more 
specific for diagnosing the etiology of pancreatitis. It is of more helpful when 
we want to diagnose the etiological factors. There are many newer tests like 
measurement of serum or urine trypsinogen which will be more specific than s. 
amylase and s. lipase. 
 
IMAGING  
                 
                               
 
Figure 13 : Ultrasound abdomen showing bulky pancreas and 
peripancreatic fluid collection 
  
Imaging studies are more helpful in diagnosing pancreatitis. Imaging 
techniques like ultrasound abdomen and computed tomography scan play a 
major role in diagnosing pancreatitis. They are done mainly to diagnose 
pancreatitis but also to detect any other abnormalities in the abdomen like any 
volvulus, or any intussusceptions. Ultrasound abdomen is very much superior 
than CT scan because in USG it can detect gall stones in a better way than CT 
scan. The findings present in USG abdomen are peripancretic fluid collection, 
bulky pancreas and increased echogenicity in the pancreas 
[3,16,18,19,27,46,48]. ( Figure 13 ) So it is used primary imaging technique in 
all children with acute and also in many cases of chronic pancreatitis.  
 
Ultrasonogram of abdomen is very much superior than CT scan because 
in USG it can detect gall stones in a better way than CT scan[49]. The main 
demerits in ultrasound technique is that the image cannot be reproduced and 
there is person to person variability who is doing ultrasound. In most of the 
children, ultrasound was done in the initial period itself at the time of 
presentation itself along with other biochemical tests USG was also done and it 
shows positive findings in a majority of children presenting with acute 
pancreatitis. Ultrasonogram of abdomen is very much superior than CT scan 
because in USG it can detect gall stones in a better way than CT scan. The main 
problems in ultrasound technique is that the image cannot be reproduced and 
there is person to person variability who is doing ultrasound. Computed 
  
tomogrphy scan is usually not initially recommended as it may not be that much 
useful in detecting pancreatitis. It is useful after diagnosing pancreatitis to find 
out any complication like pseudocyst or pancreatic necrosis or calcification 
[50,51,52]. (Figure 14). There is exposure to radiation and we should be 
cautious enough to decide whether the person needs the scan by calculating the 
risk benefit ratio. Other imaging modalities like MRCP and ERCP can also be 
done during follow up to diagnose the etiology of pancreatitis. Computed 
tomogrphy scan is usually not initially recommended as it may not be that much 
useful in detecting pancreatitis. It is useful after diagnosing pancreatitis to find 
out any complication like pseudocyst or pancreatic necrosis or calcification.   
 
                         
 
 
 
 
 
 
 
 
 
 
 
Figure 14 : CT abdomen showing pseudocyst and calcification of pancreas 
 
  
MRCP & ERCP: 
For many biliary and pancreas related condition, nowadays Magnetic 
resonance cholangopancretography (Figure 15 ) has largely replaced endoscopic 
retrgrade cholangopancretography.  
                           
 
 
 
 
 
 
 
 
 
Figure 15 : Magnetic resonance cholangiopancreatography of pancreas 
 
  
  
But both of these modalities have same accuracy and both can be of same 
sensitivity in diagnosing. But with ERCP (Figure 12), endoscopic 
sphincterotomy and stenting can be done which cannot be done by using 
Magnetic resonance cholangopancretography. 
 
 
Figure 16 : Endoscopic retrograde cholangiopancreatography of pancreas 
  
TABLE 2: DIFFERENCES BETWEEN MRCP AND ERCP
 
 
COMPLICATIONS:  
The common complications seen in children with pancreatitis are shown 
in the chart as below. 
 
 
                     
 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
                                                        
 
                                                      
 
MANAGEMENT  : 
Children with acute pancreatitis should be recognised early so that correct 
treatment measures can be undertaken to reduce the death rate of the patients. 
The important treatment measures were giving adequate hydration to correct the 
dehydration of the children. Those children will be suffering from pain, so pain 
relievers and analgesics should be prescribed. The children suffering from 
pancreatitis will be poorly nourished because of less oral intake. So they should 
be given adequate nutrition to meet thei
decrease in blood pressure can happen due to increase in the permeability of the 
 
 
  
r health needs. Hypovolemia and 
  
endothelium due to inflammatory reponse in pancreatitis children. Thus the 
intravenous fluids given early in the disease can reduce the ischemia and 
increase the oxygen delivery to the tissues. So the children presenting with 
reduced intravascular volume or in shock, usually normal saline fluid should be 
administered as bolus therapy than to lactated ringer solution. The vital 
parameter like pulse rate, blood pressure, capillary filling time and pulse volume 
should be monitored. As the children with pancreatitis will be kept nil by mouth 
and their oral intake is also poor, maintenance intravenous fluids should be 
given to maintain their nutrition.  
 
The blood sugar of the patient should be closely monitored as 
hyperglycemia should always be avoided. As the children with pancreatitis has 
abdominal pain and nausea, anti diuretic hormone will be secreted which can 
lead to hyponatremia. As these children have intolerable pain, the analgesics 
that are used routinely may not be sufficient. Powerful analgesics like tramadol 
should be given at a dose of 1mg/kg/day two to three doses in a day. Antibiotics 
and other medications such as octreotide should not be given on a routine basis 
in all children with pancreatitis.  
 
Initally it was thought that the children with acute pancreatitis should be 
kept nil by mouth so that it wont stimulate the secretion of pancreatic enzymes 
and thus it will help in faster recovery of the pancreas. But this causes 
significant increase in the morbidity of these children. Further, as compared to 
  
enteral nutrition, parenteral nutrition confers more risk of infection to the 
children. Enteral nutrition which can be given early in cases of pancreatitis may 
prevent atrophy of the mucosa of the intestine and they maintain their integrity. 
Further it also plays an important role in prevention of sepsis that occurs due to 
parenteral nutrition. 
 
There is still confusion regarding the type of enteral nutrition that can be 
given in all the children with pancreatitis who are suffering from abdominal 
pain or vomiting, a nasogastric tube should be inserted and it should be kept as 
drained by gravity so that the bowel can be decompressed . Generally a 
divergent approach is necessary for treating the children with pancreatitis. If the 
child develops complication like renal failure, those children should be 
subjected to hemodialysis and if the children has respiratory difficulty, they 
should be ventilated mechanically. 
 
                               
 
 
 
  
 
 
Figure 17: Percutaneous pseudocyst drainage 
  
In case of any fluid collections or pseudocyst,  surgical interventions   are 
usually not needed unless they cause compression on other organs. The 
endoscopic procedures usually performed are endoscopic sphincterotomy with 
stenting, endoscopic removal of gall stones and drainage of pseudocyst. 
Pancreatic enzyme supplementation should be given to all children with chronic 
pancreatitis. 
                                          
                                         
       
                               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Sphincterotomy with stenting 
 
 
 
 
  
MATERIALS AND METHODS 
 
Study design:  
Descriptive ( retrospective and prospective ) study   
 
Setting: 
       PSG hospital, Coimbatore.    
 
 
Study period:    3 years and 6 months 
        Retrospective : January 2012 - May 2014 
        Prospective  : June 2014 – July 2015 
 
 
Sample size : 
All 43 children diagnosed to have pancreatitis in PSG hospital during the 
study period.  
 
  
  
INCLUSION CRITERIA : 
 
• All children < 15 years of age in whom a diagnosis of  pancreatitis was 
made between January 2012 and July 2015 .  
 
 
 
 
 
                                          
                                              
 
 
 
 
 
 
 
                                              
  
  
METHODOLOGY 
 
            The study included all children with pancreatitis below the age of 15 
years admitted in PSG Hospital from January 2012 to July 2015. 
 
            Pancreatitis was suspected clinically if the child presented with severe 
upper abdominal pain and vomiting with or without fever. 
 
            The diagnosis of  acute  pancreatitis was made if the child met any 2 of 
the following three criteria 1)  classical abdominal  pain 2)  Elevated serum 
amylase / serum lipase more than 3 times the upper limit of normal values. 3)  
radiographic evidence of acute pancreatitis like edema or peripancreatic fluid 
collection on ultrasound abdomen or CT scan.(3)  Pancreatitis was termed as 
chronic if the abdominal imaging showed pancreatic calcification, duct 
dilatation or parenchymal atrophy.               
 
               The children were managed as per standard protocol, the details of 
which were left to the discretion of the admitting unit. 
           
For the prospective study, the child was recruited after getting an 
informed and written consent from the parents. These children were admitted 
and blood investigations like complete blood counts, C reactive protein, serum 
amylase, serum lipase, lipid profile and serum calcium and radiological 
investigations like ultrasound abdomen and xray of the abdomen were done.  
  
        History and other details in the proforma were filled up for all the children. 
 
        For the retrospective data permission was obtained from hospital 
authorities for review of case sheets. 
 
         CT scan of the abdomen, Magnetic resonance cholangiopancreatography 
(MRCP), endoscopic retrograde cholangiopancreatography ( ERCP) and upper 
gastrointestinal endoscopy  were done in selected children as decided by the 
treating physician.  
           
            
        
           
            
              
                                          
  
  
RESULTS 
 
The Study  population  included  43 children  of  which  28 children               
(65%) were diagnosed to have acute  pancreatitis  and 15 children (35%) were 
diagnosed to have  chronic  pancreatitis. 
 
ACUTE PANCREATITIS : 
The total number of children diagnosed to have acute pancreatitis              
were 28. 
 
 
 
 
 
 
 
 
                               
  
  
TABLE 3 : AGE OF THE CHILDREN AT PRESENTATION 
AGE 
NUMBER OF 
PATIENTS 
PERCENTAGE 
≤  5 YEARS 2 7.1 
6 -10 YEARS 7 25 
11 - 15 YEARS 19 67.9 
    
FIGURE 19: AGE OF THE CHILDREN AT PRESENTATION 
 
 
In the study population, among the children with acute pancreatitis, 7.1 % 
of children were less than 5 years of age; 25% of children were between 6 to 10 
years of age and 67.9% of children were between 11 to 15 years of age.( Table 3 
and Figure 19). 
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TABLE 4 :  GENDER DISTRIBUTION OF CHILDREN WITH ACUTE 
GENDER 
MALE 
FEMALE 
         
 
FIGURE  20 :  GENDER DISTRIBUTION OF CHILDREN WITH 
ACUTE PANCREATITIS
50% of the cases with acute pancreatitis
cases were females (14) . Male : female ratio is 1:1
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TABLE 5 :   ETIOLOGICAL FACTORS IN ACUTE  
PANCREATITIS 
 
ETIOLOGY N % 
CHOLELITHIASIS 3 10.7 
PANCREATIC DIVISUM 2 7.1 
DRUGS(SODIUM VALPROATE) 2 7.1 
TRAUMA 2 7.1 
HEREDITARY 2 7.1 
HYPERTRIGLYCERIDEMIA 2 7.1 
ACUTE VIRAL HEPATITIS A 1 3.6 
IDIOPATHIC 14 50 
 
 
 
 
 
                      
  
  
FIGURE 21 : ETIOLOGICAL FACTORS IN ACUTE PANCREATITIS 
 
                                                
In the study population, among children with acute pancreatitis, about         
50 % of children (14) causes were identified of which cholelithiasis constitutes 
10.7% ; pancreatic divisum in 7.1% of children; drugs ( sodium valproate) in 
7.1 % of children ; trauma in 7.1% of children ;  hereditary in 7.1% , metabolic 
cause ( hypertriglyceridemia ) in 7.1 % of children  and infection ( acute viral 
hepatitis ) in 3.6 % of children .  In the remaining 50 % of children causes were 
not known and was termed idiopathic. (Table 5 and figure 21). 
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TABLE 6 :  SYMPTOMS IN ACUTE PANCREATITIS 
 
SYMPTOMS NUMBER PERCENTAGE 
ABDOMINAL PAIN 27 96.4 
VOMITING 23 82.1 
FEVER 6 21.4 
JAUNDICE 3 10.7 
ABDOMINAL 
DISTENTION 
2 7.1 
HEMETAMESIS AND 
MELENA 
1 3.6 
 
                                       
 
 
 
  
  
FIGURE 22: SYMPTOMS IN ACUTE PANCREATITIS 
 
                  
In the study population, among children with acute pancreatitis, 96.4 % of  
children presented with abdominal pain; 82.1% with vomiting; 21.4 % 
presented with fever; 10.7 % of children presented with jaundice; 7.1 % with 
abdominal distention and 3.6% of children presented with hemetamesis/ melena. 
(Table 6 and figure 22 ). 
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TABLE 7 :  INVESTIGATIONS IN ACUTE PANCREATITIS 
 
INVESTIGATIONS N % 
RAISED LIPASE 
(more than 3 times the normal) 
28 100 
RAISED AMYLASE 
(more than 3 times the normal) 
24 85.7 
POSITIVE USG FINDINGS    27 96.4 
LEUKOCYTOSIS 14 50 
POSITIVE CRP 8 28.6 
 
 
 
 
 
 
  
FIGURE 23 : INVESTIGATIONS IN ACUTE PANCREATITIS
                 
 In the study population
in all the 100% of children.
abdomen findings suggestive of acute p
children. Elevated white blood cells was found in 50% of children; C
protein was positive in 28.6% of children; 
 
    All children (100 %) received intravenous fluids, analgesics and H
blockers / proton pump inhibit
antibiotics and 10.7% of children required endoscopic intervention
sphincterotomy with stenting in 1 child; pseudocyst drainage in 1 child and 
endoscopic removal of gall stones in 1 child)
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TABLE 8 : PSEUDOCYST IN ACUTE PANCREATITIS
PSEUDOCYST
YES 
NO 
 
 
FIGURE 24: PSEUDOCYST IN ACUTE PANCREATITIS
  
In the study population
had developed pseudocyst of pancreas.
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TABLE 9 : RECURRENCE RATE IN ACUTE PANCREATITIS
RECURRENCE
YES
NO
                             
 
FIGURE 25 : RECURRENCE RATE IN ACUTE PANCREATITIS
 
 In the study population with acute panc
atleast one recurrence of pancreatitis.
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CHRONIC PANCREATITIS 
 
Among the 43 children admitted with pancreatitis, 15 children (35%) 
were diagnosed as having chronic pancreatitis. 
                 
TABLE 10 : AGE DISTRIBUTION OF CHILDREN WITH CHRONIC 
PANCREATITIS 
AGE NUMBER OF PATIENTS PERCENTAGE 
9 - 12 YEARS 6 40 
13 - 15 YEARS 9 60 
 
FIGURE 26 : AGE DISTRIBUTION OF CHILDREN WITH CHRONIC 
PANCREATITIS 
 
 In the study population, among the children with chronic pancreatitis, 
40% of the children (6) are in the age group of  9-12 years and 60% of them (9) 
are between 13-15 years. 
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TABLE  11 : GENDER DISTRIBUTION IN CHRONIC PANCREATITIS
SEX 
FEMALE 
MALE 
 
FIGURE 27 : GENDER DISTRIBUTION IN CHRONIC PANCREATITIS
               
 In the study population, among children with chronic pancr
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TABLE 12 : ETIOLOGICAL FACTORS IN CHRONIC PANCREATITIS
ETIOLOGY
CHOLELITHIASIS 
PANCREATIC DIVISUM
HEREDITARY 
CHRONIC CALCIFIC 
PANCREATITIS 
 IDIOPATHIC 
                                  
FIGURE 28 : ETIOLOGICAL FACTORS IN CHRONIC 
In the study population with chronic pancreatitis, chronic calcific 
pancreatitis constitutes about 60% of the total cases, cholelithi
13.3 % ; pancreatic divisum 6.7%;  and hereditary in 6.7%
13.3%  of children causes were not known and was termed idiopathic.
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TABLE 13 :  SYMPTOMS IN CHRONIC PANCREATITIS
SYMPTOMS
ABDOMINAL PAIN
VOMITING 
FEVER 
JAUNDICE 
ABDOMINAL 
DISTENTION 
HEMETAMESIS / 
MELENA 
 
FIGURE 29 : SYMPTOMS IN CHRONIC PANCREATITIS
 
In the study population with chronic pancreatitis, 93.3
presented with abdominal pain; 60 % with vomiting; 20 % presented with fever; 
13.3 % of children presented with 
and 6.7 % of children presented with hemetamesis/ melena.
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TABLE 14 : INVESTIGATIONS IN CHRONIC PANCREATITIS 
INVESTIGATIONS N % 
RAISED AMYLASE 12 80 
RAISED LIPASE 14 93.3 
POSITIVE USG FINDINGS 14 93.3 
 
FIGURE 30 : INVESTIGATIONS IN CHRONIC PANCREATITIS 
 
 In the study population with chronic pancreatitis, elevated white blood 
cells was found in 20% of children; C- reactive protein was positive in 20 % of 
children; Serum Amylase was raised in 80 % while Serum lipase was elevated 
in 93.3% of children. Ultrasound abdomen findings suggestive of chronic 
pancreatitis was found in about  93.3% of children. 
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TABLE 15 : MANAGEMENT IN CHRONIC PANCREATITIS 
MANAGEMENT NUMBER PERCENTAGE 
PANCREATIC 
ENZYMES 
14 93.3 
ENDOSCOPIC 
INTERVENTION 
3 20 
                                              
FIGURE 31 : MANAGEMENT IN CHRONIC PANCREATITIS 
 
 
 In the study population, among the children with chronic pancreatitis, 
about 93.3% of children with chronic pancreatitis received pancreatic enzyme 
supplementation and 20% of children underwent endoscopic intervention. 
(endoscopic sphincterotomy with stenting in 1 children and endoscopic removal 
of gall stones in 2 children)   
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FIGURE 32 : CALCIFICATION IN CHRONIC PANCREATITIS
 
 
 In the study population with chronic pancreatitis, calcification is seen in 
60% of children with chronic pancreatitis.
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TABLE 17 : PSEUDOCYST IN CHRONIC PANCREATITIS
PSEUDOCYST
YES 
NO 
 
 
FIGURE 33 : PSEUDOCYST IN CHRONIC PANCREATITIS
 
 In the study population, pseudocyst, as a complication of chronic 
pancreatitis was found only in 
  
 
 
 FREQUENCY PERCENTAGE
3 20 
12 80 
 
20% of children. 
20%
80%
PSEUDOCYST
YES
NO
 
 
 
 
  
CLINICAL PROFILE AND OUTCOME OF ACUTE PANCREATITIS  
 
PARAMETERS Number of children Percentage 
SEX ( MALE ) 14 50 
AGE CATEGORIES 
≤   5 YEARS 
6 -10 YEARS 
11 - 15 YEARS 
 
2 
7 
19 
 
7.1 
25 
67.9 
ABDOMINAL PAIN 27 96.4 
VOMITING 23 82.1 
FEVER 6 21.4 
JAUNDICE 3 10.7 
ABDOMINAL 
DISTENTION 
2 7.1 
HEMETAMESIS/ 
MELENA 
1 3.6 
LEUKOCYTOSIS 14 50 
POSITIVE CRP 8 28.6 
RAISED AMYLASE 24 85.7 
RAISED LIPASE 28 100 
POSITIVE USG 
FINDINGS 
27 96.4 
ANALGESICS 28 100 
IV ANTIBIOTICS 18 64.3 
PSEUDOCYST 4 14.3 
RECURRENCE 13 46.4 
MORTALITY 0 0 
 
  
  
CLINICAL PROFILE AND OUTCOME OF CHRONIC PANCREATITIS  
PARAMETERS 
Number of 
children 
Percentage 
SEX ( MALE ) 6 40 
AGE CATEGORIES 
9-12 YEARS 
13-15 YEARS 
 
6 
9 
 
40 
60 
ABDOMINAL 
PAIN 
14 93.3 
VOMITING 9 60 
FEVER 3 20 
JAUNDICE 2 13.3 
ABDOMINAL 
DISTENTION 
2 13.3 
HEMETAMESIS/ 
MELENA 
1 6.7 
RAISED 
AMYLASE 
12 80 
RAISED LIPASE 14 93.3 
POSITIVE USG 
FINDINGS 
14 93.3 
PANCREATIC 
ENZYMES 
14 93.3 
PSEUDOCYST 3 20 
CALCIFICATION 9 60 
MORTALITY 0 0 
 
 
  
DISCUSSION 
 
In the present study, among 43 children with pancreatitis, 28 children had 
acute pancreatitis and 15 children had chronic pancreatitis.  
 
Among the 28 children with acute pancreatitis, 50 % of them were males 
and 50% were females. This is in accordance with other studies which showed 
no sex predilection in acute pancreatitis. While in the study by Pezzilli et al it 
was 50:50; it was 48:52 in the study by Chen & Kong et al and 57:43 in the 
study by Srikant Das et al in Delhi [25,26,28]. 
 
In our study, the mean age at presentation was 11.1 years and the median 
age was 12.5 years. In the study by Park et al, the mean age at the time of 
presentation was 13.1 years [4].  In the study by Pezzilli et al, the median age 
was 10.5 years [26], while in the study by Srikant Das et al it was 10.4 years 
[28]. In the present study, 7.1% children were less than 5 years of age, 25% 
were between 5 to 10 years of age and the remaining 67.9% were between 10-
15 years of age. This is similar to the observation in the Delhi study where 
17.9% were below 5 years of age and 28.6% were between 5 to 10 years of age 
[28]. 
 
 
  
     In our study, an etiology could be identified in only 50 % of children. 
Among them, cholelithiasis constituted 10.7%; drugs, hypertriglyceridemia, 
trauma and hereditary causes constituted 7.1% each and infection ( acute viral 
hepatitis A) in 3.6% of children. In the study from Delhi, etiology could be 
identified in 65% children. Among them, cholelithiasis constituted 10.7%; 
drugs, trauma and infections in 14.3% each; hypertriglyceridemia and hereditary 
causes in 3.6% each[28]. Another study conducted by Werlin et al, 
cholelithiasis and drugs constituted 12%; trauma and systemic disease in 14% 
and infections in 8% children [3].  In another study done in Melbourne, etiology 
could be identified in 74.9% children of which trauma constituted 36.3%, 
metabolic causes in 5.8%; biliary diseases in 5.4%; drugs in 3.2% and infectious 
causes in 2.2% [17]. In the study by Chen & Kong et al, etiology was identified 
in 73.3% children. Among them, systemic diseases were in 22.7%; biliary tract 
disease constituted 21.3% and trauma in 16% children [25]. 
 
          In our study, 14 of the 28 children (50%), a cause was not able to be 
identified. This concurs with the study from Delhi where in 35% of the children 
etiology could not be identified [28]. In the study from Melbourne, a cause was 
not identified only in 25% of children [17]. This may be due to very high 
percentage of trauma in that study.            
Abdominal pain was the most common presenting symptom in our study  
which was seen in 96.4% of children. This data was in accordance with other 
  
studies which reported 95% and above [28,24,25,27]. In our study, vomiting 
and fever were present in 82.1% and 21.4% of the children respectively. This 
was in accordance with the Delhi study in which  82% and 33.4% had vomiting 
and fever respectively. [28]. Another study by Chen & Kong in which vomiting 
and fever constituted 64.2% and 33.3% respectively[25]. In the study from 
Taiwan, vomiting and fever were seen in 35.9% and 29.5% children 
respectively. [24]. This emphasizes the already known fact that fever is not a 
significant feature of acute pancreatitis in children. 
 
In our study, among the children with acute pancreatitis, jaundice was 
noted in 10.7% children. This data is comparable with the study done by Srikant 
Das et al in which jaundice was noted in 15% of the children[28]. Another study 
by Yeung & Lee et al stated that jaundice was observed in 16.2% of the children 
with acute pancreatitis[27]. Hemetamesis / melena were present in about 3.6% 
of children in our study population. This data is similar to the study by Srikant 
Das et al in which hemetamesis/ melena were observed in 3.9% of children with 
acute pancreatitis[28]. 
 
  
  
In our study, serum lipase level was elevated in all the children (100%) 
while serum amylase was elevated in only 85.7% of the children. This is in 
accordance with the study by Tiao & Chuang et al in which serum lipase and 
serum amylase were elevated in 90% and 83.6% of the children respectively 
[24].Another study by Werlin et al showed elevation of serum lipase and 
amylase in 83% and 82% of the children respectively [3]. This implies that the 
diagnosis of acute pancreatitis will be missed in around 15% of children if only 
serum amylaseis done as the biochemical test. 
 
Ultrasound abdomen findings suggestive of acute pancreatitis was present 
in 96.4% of the children in our study. This was comparable with Srikant Das et 
al in which 83.3% of children had positive ultrasound findings[28]. But a study 
by Tiao & Chuang et al stated that only 78.4% of the children with acute 
pancreatitis had positive ultrasound findings[24]. Pseudocyst of pancreas was 
present in 14.3% of children with acute pancreatitis in our study. Other studies 
had reported 24% and 8%. [25,46] 
 
In the present study, only 10.7% of children required endoscopic 
intervention (endoscopic sphincterotomy with stenting in 1 child; pseudocyst 
drainage in 1 child and endoscopic removal of gall stones in 1 child) and the 
remaining 89.3% children were managed conservatively. Endoscopic 
intervention was required in 24.5% and 26.7% of children in both the studies 
  
fron China. [24,25]. This is probably due to the higher incidence of biliary tract 
disease in those studies. 
 
In the present study, in 28 children with acute pancreatitis, 13 (46.4%) of 
children had recurrence of pancreatitis during the study period. The recurrence 
rate with other studies were 35.7% and 28%.[26,28] In our study, recurrence 
was more common in children above 10 years of age. Among, children over 10 
years of age, recurrence of acute pancreatitis was seen in 58% compared to 22% 
of children less than 10 years of age. ( P value- 0.13 ). 
  
In the present study involving 15 children with chronic pancreatitis, mean 
age at the time of presentation was 12.7 years . In the study by  Choudhury et al 
from Vellore, the mean age at the time of presentation was 15.3 years[31]. In 
our study, 40% were males and 60% were females, while in the study from 
vellore, 60% were males and 40% were females[31].  
 
In the present study, etiology could be identified in 86.7% children with 
chronic pancreatitis. Among them, chronic calcific pancreatitis was seen in 
about 60% of the children. This is comparable to the study from vellore where it 
was reported as 68.6% and from Delhi, where it was 65.2%.[28,31] 
 
  
In our study, cholelithiasis constituted 13.3%, pancreatic divisum in 6.7% 
and hereditary causes in 6.7% children.  In the study from Delhi, cholelithiasis 
was observed in 4.3%, pancreatic divisum in 4.3% and hereditary causes in 
8.6% children.[28]. In the study from Vellore, pancreatic divisum was seen in 
8.4% and hereditary cause in 3.1% [31] 
 
In the present study, abdominal pain was the most common presenting 
symptom in 93.3% of children, while vomiting was present in 60% and fever in 
20%. This is similar to the observation of two other studies in which all children 
had abdominal pain, while fever was seen in only 26% of children.[28,31] In 
this study, jaundice was noted in  13.3 % of children. This is in accordance with 
the data by Srikant Das et al from AIIMS, NewDelhi that only 13% of the 
children with chronic pancreatitis had jaundice[28]. 
 
In our study, Serum lipase and amylase were elevated in 93.3% and 80%  
of children respectively. In another study from Delhi, serum lipase and amylase 
were elevated in 87.5% and 52.6% children respectively.[28].    
                                        
Ultrasound abdomen findings suggestive of chronic pancreatitis was 
found in about 93.3% of children in our study. This is in accordance with the 
study of Srikant Das et al, in which ultrasound abdomen findings were positive 
in 95.2% of children[28]. According to Choudhury et al, imaging studied 
  
showed changes consistent with chronic pancreatitis in 100% of children [31]. 
In the present study, pseudocyst of pancreas was present in 20% of children 
with chronic pancreatitis. In other studies,pseudocyst was present in 25% and 
17.1% of children with chronic pancreatitis. [28,31] 
 
14 of the 15 children with chronic pancreatitis in our study received 
enzyme supplements. The remaining child was started on enzyme supplements 
after the study period. All the 15 children were asymptomatic on enzyme 
supplements and diet modification. In the study by Choudhury et al, all 100% of 
children received enzyme supplements[31].  
 
  Our study confirms that in acute pancreatitis, abdominal pain and 
vomiting are the most common presenting symptoms, while fever is present in 
only 21.4% children. Among the investigations, serum lipase and ultrasound 
abdomen are diagnostic in almost all the children while serum amylase is raised 
in only 85.7% . The etiology was identified in 50% of children and among them, 
biliary calculi was the most common cause. Almost 50% of the children had 
recurrence.  
 
 In chronic pancreatitis,the most common cause is chronic calcific 
pancreatitis. Pseudocyst was seen in 20% of the children. All children were 
receiving enzyme supplements and remained asymptomatic.                             
  
LIMITATIONS: 
1. Small number of patients in the study. Pancreatitis in children being 
unusual, it was difficult to get more number of cases during the study 
period. 
 
2. MRI Cholangiogram of Genetic mutational analysis were not done for all 
the children due to financial reasons.  
                                                    
  
  
CONCLUSIONS 
 
1) Among the 43 children included in the study, 28 (65%) had acute 
pancreatitis and 15 (35%) had chronic pancreatitis. 
 
2) The most common identifiable cause of acute pancreatitis was biliary 
calculi (10.7%) followed by drugs and trauma(7.1%). Around 50% had 
no identifiable cause. 
 
3) Among the children with acute pancreatitis, more than 95% of the 
children had upper abdominal pain, and vomiting was present in around 
80% of the children while only 20% had fever.  
 
4) All the children with acute pancreatitis had elevated serum lipase while   
serum amylase was elevated only in 85% of the children. 
 
5) About 46.4% of children who presented with acute pancreatitis had 
recurrence during the study period. Recurrence was more common in 
children above 10 years of age. Among the children over 10 years of age, 
recurrence of acute pancreatitis was seen in 58% compared to 22% of 
children less than 10 years of age. 
  
6) Among the children with chronic pancreatitis, more than 90%  had upper 
abdominal pain, while vomiting was present in around 60%  and only 
20% had fever. 
 
7)  93% of the children with chronic pancreatitis had elevated serum lipase 
levels and 80% had elevated serum amylase levels. 
 
8)  The most common identifiable cause of chronic pancreatitis was chronic   
calcific pancreatitis (60%) followed by cholelithiasis (13.3%) and 
pancreatic divisum (6.7% ). No cause was identified in 13.3% of children. 
 
9) All children with chronic pancreatitis were receiving enzyme 
supplements   and remained asymptomatic.     
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ABBREVATIONS 
USG                -       Ultrasonogram 
CT                   -       Computed Tomography 
MRCP             -       Magnetic Resonance Cholangio Pancreatography 
ERCP              -       Endoscopic Retrograde Cholangio Pancreatography 
SGPT              -       Serum Glutamate Pyruvate Transaminase 
SGOT             -       Serum glutamic oxaloacetic transaminase 
CRP                -        C - reactive protein 
SMA               -        Superior mesenteric artery 
IVC                 -        Inferior vena cava 
HUS                -        Hemolytic Uremic Syndrome 
SLE                -        Systemic lupus erythematosus 
ARDS             -        Acute respiratory distress syndrome 
SPINK1          -         Serine protease inhibitor Kazal type 1 
PRSS 1           -         protease serine 1 
TNF alpha     -       Tumour necrosis factor alpha 
DNA             -        Deoxyribonucleic acid 
 
  
PROFORMA 
 
TITLE OF THE STUDY :  Clinical profile and outcome of pancreatitis in 
children aged less than 15 years. 
 
NAME     : 
AGE     : 
SEX       : 
OP NO.   :  
IP NO : 
 
HISTORY OF PRESENT ILLNESS ( TICK ) 
                 a)Abdominal pain (     ) 
                 b)Nausea and vomiting (     ) 
                 c) hematemesis and melena (    ) 
                 d) Abdominal distention (    ) 
                 e) Fever ( 
                 f)Jaundice (     ) 
 
PAST HISTORY ( TICK ) 
a) H/o Recent infection (    ) 
b) H/o Trauma (    ) 
c) H/o Drug intake (     ) 
d) H/o systemic disease (     ) 
e) Family h/o (      ) 
f) H/o surgery (     ) 
g) H/o metabolic disorders (    ) 
 
  
  
INVESTIGATIONS : 
a) complete blood count 
b) random blood sugar 
c) CRP 
d) s.amylase and lipase 
e) s.calcium 
f) lipid profile 
g) liver function test 
h) renal function test 
i) blood c/s 
j) x-ray chest and abdomen 
k) USG abdomen 
l) CT abdomen 
m)  MRCP 
n) Sweat chloride test 
o) Alpha-1 antitrypsin deficiency 
 
TREATMENT : 
                  IV fluids, diet, antibiotics, analgesics, enzyme supplements, surgery 
 
RECURRENCE RATE  : 
 
COMPLICATIONS :  
 
 
 
  
  
SOP 03-V 3.0 / ANX 09-V 2.0 
 
Institutional Human Ethics Committee 
PSG Institute of Medical Sciences and Research, Coimbatore 
 
Assent to be in a Research Study 
For children between 7-18 years old 
 
Why are we meeting with you? 
 
We want to tell you about something we are doing called a research study.  A research study is 
when doctors collect a lot of information to learn more about something related to health and 
disease..  Dr Senthil Aakash and some other doctors are doing a study to learn more about 
CLINICAL PROFILE AND OUTCOME OF PANCREATITIS IN CHILDREN AGED LESS 
THAN 15 YEARS . After we tell you about it, we will ask if you’d like to be in this study or not. 
 
Why are we doing this study? 
 
 We want to find out CLINICAL PROFILE AND OUTCOME OF PANCREATITIS IN 
CHILDREN AGED LESS THAN 15 YEARS .  
 So we are getting information from lots of boys and girls like you. 
  In the whole study, there will be about 45 children. 
 
What will happen to you if you are in this study? 
 
Only if you agree, two things will happen: 
 
1. A small amount of your blood will be drawn.  That means it will be taken by a needle in 
your arm.  This will happen only once.  
 
  
Will this study hurt? 
 
The stick from the needle to draw your blood will hurt, but the hurt will go away after awhile.   
 
Will you get better if you are in this study? 
No, this study won’t make you feel better or get well.  But the doctors might find out something 
that will help other children like you later. 
 
Will everybody come to know about my condition? (Confidentiality) 
We will not tell other people that you are in this research and we won't share information about    
you to anyone who does not work in the research study 
 
 
 
Is this bad or dangerous for me? (Risks involved)  
   no there is no risk involved 
 
  
  
 
Do I get anything for being in the research?  
   no 
 
 
Will you tell me the results? 
Yes we will tell u the results when ever you want to know. This results will also be published in a 
book for research purpose. But we will not reveal your name in it . 
 
 
 
Do you have any questions? 
You can ask questions any time.  You can ask now.  You can ask later.  You can talk to me or 
you   can talk to someone else. 
 
 
Do you have to be in this study? 
No, you don’t.  No one will be mad at you if you don’t want to do this.  If you don’t want to be in 
this study, just tell us.   Or if you do want to be in the study, tell us that.  And, remember, you can 
say yes now and change your mind later.  It’s up to you. This will not affect in any way your 
future treatment in this hospital. 
 
 
Who can I talk to or ask questions to? 
List and give contact information for those people who the child can contact easily (a local person 
who can actually be contacted). Tell the child that they can also talk to anyone they want to about 
this (their own doctor, a family friend, a teacher). 
 
 
If you don’t want to be in this study, just tell us. If you want to be in this study, just tell us. This 
will not affect in any way your future treatment in this hospital. 
The doctor will give you a copy of this form to keep. 
 
 
SIGNATURE OF PERSON CONDUCTING ASSENT DISCUSSION 
I have explained the study to ______________________(print name of child here) in language 
he/she can understand, and the child has agreed to be in the study. 
 
 
__________________________________   _______________ 
Signature of Person Conducting Assent Discussion  Date 
 
_______________________________ 
Name of Person Conducting Assent Discussion (print) 
 
 
 
Dr. SENTHIL AAKASH.K 
  
  
Certificate of Assent 
 
 
I have read this information (or had the information read to me)  I have had my questions 
answered and know that I can ask questions later if I have them.  
 
I agree to take part in the research. 
 
OR 
I do not wish to take part in the research and I have not signed the assent below.___________ 
(initialed by child/minor) 
 
Only if child assents: 
Print name of child ___________________ 
Signature of child: ____________________ 
Date:________________ 
           day/month/year    
 
 
If illiterate: 
A  literate witness must sign (if possible, this person should be selected by the participant, not be 
a parent, and should have no connection to the research team). Participants who are illiterate 
should include their thumb print as well.   
 
I have witnessed the accurate reading of the assent form to the child, and the individual has had 
the opportunity to ask questions. I confirm that the individual has given consent freely.  
 
Print name of witness (not a parent)_________________  AND    Thumb print of participant 
Signature of witness ______________________ 
Date ________________________ 
                Day/month/year 
  
 
 
 
 
 
I have accurately read or witnessed the accurate reading of the assent form to the potential 
participant, and the individual has had the opportunity to ask questions. I confirm that the 
individual has given assent freely.  
 
Print name of researcher_________________ 
 
  
 
  
PSG Institute of Medical Science and Research, Coimbatore 
Institutional Human Ethics Committee 
INFORMED CONSENT FORMAT FOR RESEARCH PROJECTS 
 
 
 
I     K. SENTHIL AAKASH   carrying out a study on the topic:  CLINICAL PROFILE AND OUTCOME OF 
PANCREATITIS IN CHILDREN AGED LESS THAN 15 YEARS – DESCRIPTIVE( RETROSPECTIVE AND 
PROSPECTIVE) STUDY 
 
   
My  research guide is: Dr.JOHN MATTHAI 
 
The justification for this study is there is a paucity of literature regarding the profile of pancreatic 
disorders in children. The divergence of opinion between authors regarding etiology, 
pathophysiology, definitions and classification of pancreatic disorders and non-uniformity of 
vocabulary makes it difficult to compare different studies. From our country, only case 
reports of various pancreatic disorders in children were available. The present study is to 
determine the profile and outcome of pancreatic disorders in children presenting to our 
hospital 
 
The objectives of this study are:  
 
Primary Objective:  To study the etiology and presentation of acute and chronic pancreatitis in children and 
to manage accordingly 
 
Secondary Objective:  To determine the complication and recurrence rate of both acute and chronic 
pancreatitis in children. 
 
Sample size:   45 
 
Study volunteers / participants are (specify population group & age group) 
  
Children with pancreatitis ( less than 15 years old )  
 
Location:  Department of paediatrics, PSG IMSR 
 
We request you to kindly cooperate with us in this study. We propose collect background information and 
other relevant details related to this study. We will be carrying out:  
 
.  
 
Data collected will be stored for a period of five years    We will not use the data as part of another study. 
 
Clinical examination AND  
Blood sample collection: it varies depending upon the clinical condition of the child .  
 
  
Whether blood sample collection is part of routine procedure or for research (study) purpose:  routine 
procedure 
 
Specify purpose, discomfort likely to be felt and side effects, if any: no discomfort or side effects 
 
Whether blood sample collected will be stored after study period:  No, it will be destroyed 
 
Whether blood sample collected will be sold:    No  
 
Whether blood sample collected will be shared with persons from another institution: No 
 
Medication given, if any, duration, side effects, purpose, benefits: no medication is used. 
Benefits from this study   : identification of most common etiological factors, presenting symptoms, 
complications involved and rate of recurrence in pancreatitis patients. 
 
Risks involved by participating in this study :no risks involved 
 
How the results will be used: results will be used to assess the morbidity pattern of pancreatitis patients . 
 
 
If you are uncomfortable in answering any of our questions during the course of the interview / biological 
sample collection, you have the right to withdraw the baby from the study at anytime. You have the 
freedom to withdraw your child from the study at any point of time. Kindly be assured that your refusal to 
participate or withdrawal at any stage, if you so decide, will not result in any form of compromise or 
discrimination in the services offered nor would it attract any penalty. You will continue to have access to the 
regular services offered to your child. You will NOT be paid any remuneration for the time you spend with us 
for this interview / study. The information provided by you will be kept in strict confidence. Under no 
circumstances shall we reveal the identity of the respondent or their families to anyone. The information that 
we collect shall be used for approved research purposes only. You will be informed about any significant 
new findings - including adverse events, if any, developed during the course of this research which may 
relate to your willingness to continue participation. 
 
Consent: The above information regarding the study, has been read by me/ read to me, and has been 
explained to me by the investigator/s. Having understood the same, I hereby give my consent to them to 
enroll my child in this study. . I am affixing my signature / left thumb impression to indicate my consent and 
willingness to enroll my baby  in this study (i.e., willingly abide by the project requirements).  
 
Signature / Left thumb impression of the parent :  
 
 
 
Signature of the researcher: 
Contact no:9600939977    . department extension number : 5140 , 
                                             tks.cbe@gmail.com                              
IHEC CONTACT NO:0422 2570170  EXTENSION NO:5818 
Witness: 
 
  
  
  
Institutional Human Ethics Committee 
PSG Institute of Medical Sciences and Research, Coimbatore 
 
Parental Consent Form 
 
Title of Study: CLINICAL PROFILE AND OUTCOME OF PANCREATITIS IN CHILDREN 
AGED LESS THAN 15 YEARS – DESCRIPTIVE( RETROSPECTIVE AND PROSPECTIVE) 
STUDY 
 
Name of the Principal Investigator: K. SENTHIL AAKASH 
 
Department: PAEDIATRICS 
 
Your child is invited to participate in a study of pancreatitis in children based on their presentation 
and outcome.   
 
My name is K. SENTHIL AAKASH  and I am a Post Graduate at PSG Institute of Medical Sciences 
and Research, Coimbatore. This study is done to know the manifestations and outcome of pancreatitis 
in children So that it would be an evidence for management of the condition in future. 
 
I am asking for permission to include your child in this study because I expect to have Minimum 45 
participants in the study. 
 
If you allow your child to participate, I will collect medical details from your babies case record. 
 
Any information that is obtained in connection with this study and that can be identified with your 
child will remain confidential and will be disclosed only with your permission. His or her responses 
will not be linked to his or her name or your name in any written or verbal report of this research 
project. 
 
Your decision to allow your (son/daughter/child/infant/adolescent youth) to participate will not affect 
your or his or her present or future relationship with PSGIMS&R or PSG Hospitals. If you have any 
questions about the study, please ask me. If you have any questions later, call me at 9600939977 If 
you have any questions or concerns about your (son/daughter/child/infant/adolescent youth)’s 
participation in this study, call 9600939977. 
 
You may keep a copy of this consent form. 
You are making a decision about allowing your child to participate in this study. Your signature 
below indicates that you have read the information provided above and have decided to allow him or 
her to participate in the study. If you later decide that you wish to withdraw your permission for your 
child to participate in the study, simply tell me. 
 
You may discontinue his or her participation at any time. This will not affect in any way your future 
treatment in this hospital. 
 
Printed Name of the child : 
 
 
Signature of Parent(s) or Legal Guardian with Date  Signature of Investigator with Date 
  
  
kåj cçik nfh£ghLfŸ FG 
PSG kU¤Jt¡  fšÿç k‰W« kU¤Jtkid, nfhit 
Ïªj MuhŒ¢Á gÂidªJ taJ¡F£g£l FHªijfël« brŒa¥gL»wJ. 
 
eh« vj‰F rªÂ¡»nwh« ? 
eh§fŸ muhŒ¢Á go¥ig¥ g‰¿¡ Tw éU«ò»nwh«. MuhŒ¢Á go¥ò v‹gJ 
kU¤Jt®fŸ xU F¿¥Ã£l kU¤Jt jftšfis nrfç¤J mij¥ g‰¿ bjçªJ bfhŸtJ. 
 
eh‹ Dr. f. brªÂš MfhZ, gÂidªJ taJ¡F£g£l FHªijfëš fiza 
mH‰Á ( ng‹»çahil£o°) nehæ‹ j‹ik k‰W« éisÎfis MuhŒ»nw‹. 
 
vj‰fhf Ïªj¥ gçnrhjid ? 
Ïj‹ _y«, gÂidªJ taJ¡F£g£l FHªijfëš fiza mH‰Á 
(ng‹»çahil£o°) nehæ‹ j‹ik k‰W« éisÎfis bjçªJ bfhŸtj‰fhf, 
Ïj‰fhf ãiwa jftšfis M©  k‰W« bg© FHªijfël« ÏUªJ bgW»nwh«. 
Ïªj MŒéš bkh¤jkhf 45 FHªijfŸ cŸsd®. Ïªj gçnrhjid _y« 
c§fSila bjhªjuÎfŸ rçbrŒa¥glkh£lhJ. 
Mdhš Ïªj gçnrhjid _y« Ãw FHªijfS¡F cgnahfkhf ÏU¡F«. 
c§fë‹ gçnrhjidæ‹ KoÎfŸ ntW ahU¡F« brŒa¥gl kh£lhJ. 
c§fS¡F k£Lnk bjça¥gL¤j¥gL« Ïªj gçnrhjidæš c§fS¡F rªnjf« 
ÏUªjhš  lh¡l®.  brªÂš MfhZ – 9600939977 bjhl®ò¡bfhŸsÎ«.  
Ïªj  gçnrhjidæš Ú§fŸ g§F bfhŸs nt©L« v‹w f£lha« Ïšiy. 
c§fS¡F éU¥g« Ïšiy v‹whš ÏÂš ÏUªJ v¥nghJ« nt©LkhdhY« 
éy»¡ bfhŸsyh«. 
Ïjdhš Ïªj kU¤Jtkidæ‹ vªj rYiffS« Fiw¡f¥gl kh£lhJ. 
lh¡l®.  brªÂš MfhZ M»a eh‹ Ïªj nrhjidia¥ g‰¿ mid¤J 
jftšfisÍ«, FHªijfë‹ bg‰nwh®fS¡F jäêš T¿ÍŸns‹. 
FHªijæ‹ bg‰nwh® mij e‹F òçªJ ÃwF Ïj‰F r«kj« bjçé¤JŸsd®. 
c§fël« Ïªj nehia¥ g‰¿ Áy nfŸéfŸ nf£f¥gL«. òÂa gçnrhjid vJÎ« 
brŒa¥glhJ. 
Ïªj gçnrhjid tH¡fkhf brŒa¥gL« gçnrhjid k£Lnk. 
Ïªj gçnrhjidæ‹ Koit k£Lnk vdJ MŒÎ¡F vL¤J¡bfhŸnt‹. 
 
 
MŒÎ¡F£g£ltç‹ ifbah¥g«                                       MŒthsç‹ ifbah¥g« 
njÂ : 
  
gFÂ – 2 
r«kj rh‹W 
eh‹ Ïªj¡ jftiy¥ go¤nj‹ (mšyJ) jftiy go¡f¡ nf£nl‹ vdJ 
nfŸéfS¡F¥ gÂš më¡f¥g£lJ k‰W« nfŸéfŸ vJÎ« ÏUªjhš mitfis 
tU§fhy¤Âš nf£fyh« v‹gJ« vd¡F¤ bjçÍ«. 
eh‹ Ïªj MuhŒ¢Áæš g§nf‰f r«kÂ¡»nw‹. 
mšyJ 
eh‹ Ïªj MuhŒ¢Áæš g§nf‰f éU¥g« Ïšiy k‰W« ÑnH r«kj« v‹W 
ifbah¥g« brŒaéšiy. ......................................................................................... . 
(FHªij / ikd® / ÏåÁaš brŒa¥g£LŸsJ) 
 
FHªij k£L« r«kj« bjçé¤jhš 
FHªijæ‹ bga®  : 
FHªijæ‹ ifbaG¤J : 
njÂ    : 
 
go¥g¿Î Ïšyhjtuhf ÏUªjhš go¥g¿Î cŸs rh£Á ifbah¥g« brŒa nt©L« 
(Koªjhš  Ïªj eg® fyªJ bfhŸtguhš nj®ªbjL¡f¥gl nt©L«. Ïªj eg® bg‰nwhuhf 
ÏU¡f¡TlhJ. k‰W« mtU¡F MuhŒ¢Á FGél« vªj bjhl®ò« ÏU¡f¡TlhJ). 
eh‹ r«kj« got¤ij FHªijæl« rçahf go¤J¡ fh©Ã¤jij¥ gh®¤nj‹. 
k‰W« mªj egU¡F nfŸéfŸ nf£f thŒ¥ò ÏUªjJ. mªj eg® jdJ r«kj¤ij KG 
kdJl‹ bfhL¤jh® v‹gij eh‹ cWÂ TW»nw‹. 
 
rh£ÁfŸ    : 
rh£Áæ‹ ifbaG¤J : 
njÂ    : 
 
fyªJ bfhŸgtç‹ ÏlJ 
bgUéuš nuif 
MuhŒ¢Á brŒgtç‹ 
bga®    : lh¡l®  K. brªÂš MfhZ 
     ifngÁ v©. 96009 39977 
  
  
S.NO IP NO OP NO AGE SEX
ABDOMINAL 
PAIN
VOMITING FEVER JAUNDICE
ABDOMINAL 
DISTENTION
HEMATAMESIS 
AND
 MELENA
CHOLELITHIASIS
PANCREATIC
 DIVISUM
DRUG 
INDUCED
HEREDITARY TRAUMA
METABOLIC 
DISORDERS
RECENT 
INFECTION
LEUKOCYTOSIS
RAISED   
CRP
RAISED S. 
AMYLASE
RAISED S.
LIPASE
ABNORMAL 
LIPID
 PROFILE
ABNORMAL 
LFT
POSITIVE 
USG 
FINDINGS
ABNORMAL
 XRAY
POSITIVE CT/
MRI FINDINGS
IV 
FLUIDS
IV 
ANTIBIOTICS
ANALGESICS
H2 BLOCKERS/ 
PPIs
ENDOSCOPIC 
INTERVENTION
DURATION OF 
HOSPITAL STAY
PSEUDOCYST RECURRENCE
1 I12003620 O11081959 8 M 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 0 2 1 0 1 1 0 5 0 0
2 I13027678 O11075628 14 F 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 0 0 1 0 1 1 0 4 0 1
3 I14019181 O11075651 12 M 1 0 1 0 0 0 0 0 0 0 0 0 0 1 0 1 1 2 0 1 2 2 1 1 1 1 0 7 1 1
4 I14030531 O14073448 14 F 1 1 0 0 0 0 1 0 0 0 0 0 0 1 0 1 1 0 0 1 2 0 1 1 1 1 0 6 0 1
5 I15021321 O10074650 12 F 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 2 2 1 2 2 1 1 1 1 0 5 0 1
6 I12022441 O12056218 9 M 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 2 1 0 1 1 0 4 0 0
7 I13014394 O13032953 13 M 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 1 2 2 1 0 1 1 0 3 0 1
8 I14020330 O14048253 11 F 1 1 1 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 1 1 0 1 1 1 1 0 6 0 0
9 I15000216 O15000451 6 F 1 0 1 1 1 0 0 0 0 0 0 0 1 0 0 1 1 0 0 1 0 2 1 0 1 1 0 6 0 0
10 I14023521 O14057031 6 F 1 1 0 0 0 0 1 0 0 0 0 0 0 1 0 1 1 0 1 1 0 0 1 1 1 1 1 8 0 1
11 I12027792 O12070571 14 M 1 1 1 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 1 0 0 1 1 1 1 0 5 1 0
12 I12027650 O12070153 5 M 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 2 2 1 1 1 1 0 6 0 0
13 I12008492 O12020967 13 F 1 0 0 0 0 0 0 0 1 0 0 0 0 1 0 1 1 0 1 1 0 2 1 1 1 1 0 5 0 0
14 I12008376 O12020741 6 F 1 1 0 1 0 0 0 1 0 0 0 1 0 1 1 1 1 0 1 1 2 2 1 1 1 1 0 7 0 0
15 I12028486 O11075628 15 F 1 1 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0 1 2 2 1 0 1 1 0 3 0 0
16 I12027704 O10074650 12 F 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0 0 1 0 2 1 0 1 1 0 7 0 0
17 I13037959 O13090736 4 F 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 1 1 0 0 1 0 2 1 1 1 1 0 7 0 1
18 I13033983 O13065163 15 M 1 1 1 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 0 2 1 1 1 1 0 6 0 1
19 I12000551 O12001397 15 M 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 0 1 1 0 1 1 0 5 0 1
20 I12001258 O12003360 15 F 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 0 1 1 0 1 1 0 4 0 1
21 I13000269 O13000566 15 F 1 1 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 1 0 1 1 1 1 1 0 6 0 0
22 I13002734 O13005995 14 M 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 1 0 1 1 1 1 1 0 4 0 1
23 I13023861 O13056049 13 F 1 1 0 0 0 0 1 0 0 0 0 0 0 1 1 1 1 0 0 1 1 0 1 1 1 1 1 4 0 1
24 I14004130 O13052326 15 M 1 1 0 1 1 0 0 1 0 0 0 1 0 1 0 0 1 1 1 1 0 1 1 1 1 1 0 4 0 1
25 I15002265 O15004954 15 M 1 1 0 0 0 0 0 0 1 0 0 0 0 1 1 1 1 0 0 1 0 1 1 1 1 1 0 8 1 0
26 I14020448 O14048503 6 M 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0 1 0 2 1 1 1 1 0 4 0 0
27 I14014214 O14033707 6 M 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 1 1 0 1 1 1 4 0 0
28 I14007595 O14019356 9 M 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 1 1 1 1 1 1 1 0 15 1 0
MASTER CHART  
Acute Pancreatitis: 
  
S.NO IP NO OP NO AGE SEX
ABDOMINAL 
PAIN
VOMITING FEVER JAUNDICE
ABDOMINAL
 DISTENTION
HEMATAMESIS 
AND MELENA
DRUG 
INDUCED
CHOLELITHIASIS
PANCREATIC 
DIVISUM
FAMILY 
HISTORY
LEUKOCYTOSIS
RAISED 
CRP
RAISED S. 
AMYLASE
RAISED S. 
LIPASE
ABNORMAL 
LIPID 
ABNORMAL
 LFT
ABNORMAL USG 
ABDOMEN
ABNORMAL 
CT/MRI
MRCP/
 ERCP
GENETIC 
ANALYSIS
IV 
FLUIDS
IV 
ANTIBIOTICS
ANALGESICS
H2 BLOCKERS/ 
PPIs
DIETARY 
MODIFICATIONS
PANCREATIC
 ENZYMES
ENDOSCOPIC
INTERVENTIO
PSEUDOCYST ASCITES CALCIFICATION
1 I14017568 O14041589 13 F 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 1 1 2 1 0 1 1 1 1 0 0 0 1
2 I15013647 O15029016 13 F 1 1 0 0 0 1 0 0 0 0 1 0 1 1 0 0 1 1 1 2 1 1 1 1 1 1 0 0 0 1
3 I15017263 O15028434 10 M 1 0 0 0 0 0 0 0 1 0 0 0 1 1 0 0 1 2 1 2 1 0 1 1 1 1 1 1 0 1
4 I15016356 O15035867 14 M 1 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 2 2 1 0 1 1 1 1 0 0 0 0
5 I13022477 O11082542 12 F 1 0 1 0 0 0 0 0 0 0 1 1 1 1 0 0 1 2 2 2 1 1 1 1 1 1 0 0 0 0
6 I14003619 O14009209 9 M 1 1 0 0 1 0 0 0 0 0 0 0 1 1 0 0 1 2 1 2 1 1 1 1 1 1 0 0 1 1
7 I12028087 O12071001 13 F 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 0 1 2 2 1 1 0 1 1 1 1 0 0 0 1
8 I12022025 O12055112 14 F 1 1 0 1 0 0 0 1 0 0 0 0 0 1 0 1 1 1 1 2 1 1 1 1 1 1 1 1 0 0
9 I14001203 O14003193 15 M 1 1 1 0 0 0 0 0 0 0 1 1 1 1 0 0 1 2 2 2 1 1 1 1 1 1 0 0 0 1
10 I13037900 O08002145 11 F 0 1 0 0 1 0 0 0 0 0 0 0 1 1 0 0 1 1 1 2 1 1 0 1 1 0 0 0 1 0
11 I12001273 O12000748 15 M 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 1 1 2 1 1 1 1 1 1 0 0 0 1
12 I12037285 O12092670 14 F 1 1 0 1 0 0 0 1 0 0 0 0 1 1 0 1 1 1 1 2 1 1 1 1 1 1 1 1 0 0
13 I14032692 O14078180 15 F 1 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 2 2 1 0 1 1 1 1 0 0 0 1
14 I15013431 O14020279 11 M 1 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 2 1 0 1 1 1 1 0 0 0 1
15 I13009159 O13021309 12 F 1 1 1 0 0 0 0 0 0 0 0 1 1 0 0 0 1 1 2 2 1 1 1 1 1 1 0 0 0 0
Chronic Pancreatitis: 
 
0 - No 
1 - Yes 
2 - Not done.  
 
